Surgical Science Sweden AB Forecast, price target & analysts
Surgical Science Sweden AB Target price 2026 - Analyst rating & recommendation
Surgical Science Sweden AB Classifications & Recommendation
Surgical Science Sweden AB Price Target
| Target Price | kr62.73 |
| Price | kr53.30 |
| Potential |
17.69%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Surgical Science Sweden AB 2027 .
The average Surgical Science Sweden AB target price is kr62.73.
This is
17.69%
register free of charge
kr93.45
75.33%
register free of charge
kr60.60
13.70%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Surgical Science Sweden AB to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Surgical Science Sweden AB stock has an average upside potential 2027 of
17.69%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 0.99 | 1.03 |
| 12.24% | 4.00% | |
| EBITDA Margin | 18.16% | 22.34% |
| 20.84% | 22.99% | |
| Net Margin | 6.73% | 10.95% |
| 54.78% | 62.62% |
5 Analysts have issued a sales forecast Surgical Science Sweden AB 2026 . The average Surgical Science Sweden AB sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Surgical Science Sweden AB EBITDA forecast 2026. The average Surgical Science Sweden AB EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Surgical Science Sweden AB Analysts have issued a net profit forecast 2026. The average Surgical Science Sweden AB net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 1.31 | 2.21 |
| 49.22% | 68.70% | |
| P/E | 24.07 | |
| EV/Sales | 1.89 |
5 Analysts have issued a Surgical Science Sweden AB forecast for earnings per share. The average Surgical Science Sweden AB EPS is
This results in the following potential growth metrics and future valuations:
Surgical Science Sweden AB...
Current Surgical Science Sweden AB Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Aug 21 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | Aug 20 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | May 21 2026 |
| PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | May 20 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | May 20 2026 |
| DNB CARNEGIE |
Locked
➜
Locked
|
Locked | May 19 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Aug 21 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
Aug 20 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
May 21 2026 |
|
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
May 20 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
May 20 2026 |
|
Locked
DNB CARNEGIE:
Locked
➜
Locked
|
May 19 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
